KR101912774B1 - 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 - Google Patents

포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 Download PDF

Info

Publication number
KR101912774B1
KR101912774B1 KR1020160154978A KR20160154978A KR101912774B1 KR 101912774 B1 KR101912774 B1 KR 101912774B1 KR 1020160154978 A KR1020160154978 A KR 1020160154978A KR 20160154978 A KR20160154978 A KR 20160154978A KR 101912774 B1 KR101912774 B1 KR 101912774B1
Authority
KR
South Korea
Prior art keywords
obesity
strain
formic acid
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020160154978A
Other languages
English (en)
Korean (ko)
Other versions
KR20180056972A (ko
Inventor
이명기
임상동
이성훈
조용선
남영도
배진주
Original Assignee
한국식품연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품연구원 filed Critical 한국식품연구원
Priority to KR1020160154978A priority Critical patent/KR101912774B1/ko
Priority to PCT/KR2017/013297 priority patent/WO2018093238A2/ko
Priority to US16/462,901 priority patent/US11564955B2/en
Priority to JP2019547566A priority patent/JP7012736B2/ja
Publication of KR20180056972A publication Critical patent/KR20180056972A/ko
Application granted granted Critical
Publication of KR101912774B1 publication Critical patent/KR101912774B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • Y10S514/866—
    • Y10S514/909—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020160154978A 2016-11-21 2016-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 Active KR101912774B1 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020160154978A KR101912774B1 (ko) 2016-11-21 2016-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
PCT/KR2017/013297 WO2018093238A2 (ko) 2016-11-21 2017-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
US16/462,901 US11564955B2 (en) 2016-11-21 2017-11-21 Composition including, as active ingredient, strain having ability to produce formic acid for preventing or treating obesity or metabolic syndromes caused by obesity
JP2019547566A JP7012736B2 (ja) 2016-11-21 2017-11-21 ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160154978A KR101912774B1 (ko) 2016-11-21 2016-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물

Publications (2)

Publication Number Publication Date
KR20180056972A KR20180056972A (ko) 2018-05-30
KR101912774B1 true KR101912774B1 (ko) 2018-10-29

Family

ID=62145598

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160154978A Active KR101912774B1 (ko) 2016-11-21 2016-11-21 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물

Country Status (4)

Country Link
US (1) US11564955B2 (enExample)
JP (1) JP7012736B2 (enExample)
KR (1) KR101912774B1 (enExample)
WO (1) WO2018093238A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210130076A (ko) 2020-04-21 2021-10-29 한국식품연구원 포름산 생성능이 우수한 엔테로코커스 패칼리스 tk1 균주, 이를 포함하는 항비만용 식품 조성물 및 이의 제조방법

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4074324A4 (en) * 2019-10-24 2024-02-28 Doctor TJ Co., Ltd. COMPOSITION CONTAINING ENTEROCOCUS FAECALIS AS ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF OBESITY OR METABOLIC SYNDROMES INDUCED THEREBY
JP7153274B2 (ja) * 2019-12-25 2022-10-14 京都府公立大学法人 慢性腎臓病進行抑制剤
EP4082555A4 (en) * 2019-12-27 2024-01-24 National University Corporation Kobe University AGENT FOR INHIBITING CAPILLARY BLOOD VESSEL DISORDER, AGENT FOR IMPROVING CAPILLARY BLOOD VESSEL DISORDER AND AGENT FOR ACCELERATING CAPILLARY BLOOD VESSEL DISORDER
CN115245523A (zh) * 2021-01-28 2022-10-28 上海市第六人民医院 青春双歧杆菌在制备脂肪吸收抑制剂中的应用
CN114042091A (zh) * 2021-10-24 2022-02-15 郑州大学 酪黄肠球菌在制备治疗代谢综合征产品中的应用方法
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
IT202200013138A1 (it) * 2022-06-22 2023-12-22 Cerbios Pharma Sa Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità
CN117625478A (zh) * 2023-11-29 2024-03-01 广西爱生生命科技有限公司 一种具有治疗非酒精性脂肪肝和/或减脂功能的戊糖片球菌菌株a21243及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101508586B1 (ko) * 2013-10-21 2015-04-08 한국식품연구원 비만억제능이 우수한 신규한 엔테로코커스 휘칼리스 md366 균주
KR101611829B1 (ko) * 2015-06-08 2016-04-14 주식회사 쎌바이오텍 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63280027A (ja) 1987-05-11 1988-11-17 Nichinichi Shokuhin Kk 抗高脂血症剤
US6787348B1 (en) * 1998-08-26 2004-09-07 Chr. Hansen Liquid starter cultures having improved storage stability and use thereof
DE19854402A1 (de) 1998-11-25 2000-05-31 Hassan Jomaa Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen
JP4666736B2 (ja) 2000-09-05 2011-04-06 花王株式会社 高血圧症予防・改善・治療剤
WO2005077390A1 (ja) 2004-02-16 2005-08-25 Yasuo Kawai 血糖値低下剤、糖尿病治療・予防剤及びその製造方法
JP5569710B2 (ja) * 2009-02-27 2014-08-13 国立大学法人広島大学 肥満予防又は改善剤
KR101271538B1 (ko) 2011-06-24 2013-06-05 (주)이뮤노텍 유기산, ｌ―카르니틴, ｌ―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물
EP2716167A1 (en) 2012-10-02 2014-04-09 Lunamed AG Non-pharmaceutical composition comprising short chain fatty acids
KR20160066253A (ko) 2014-12-02 2016-06-10 (주)아모레퍼시픽 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물
CN109219656B (zh) 2016-09-06 2025-12-09 深圳华大生命科学研究院 长栖粪杆菌（Faecalibacterium longum）及其应用
EP3511407B1 (en) 2016-09-06 2023-05-17 BGI Shenzhen Christensenella intestinihominis and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101508586B1 (ko) * 2013-10-21 2015-04-08 한국식품연구원 비만억제능이 우수한 신규한 엔테로코커스 휘칼리스 md366 균주
KR101611829B1 (ko) * 2015-06-08 2016-04-14 주식회사 쎌바이오텍 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Bratial lek Listy. 106(2). pp.67~72. (2005)*

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210130076A (ko) 2020-04-21 2021-10-29 한국식품연구원 포름산 생성능이 우수한 엔테로코커스 패칼리스 tk1 균주, 이를 포함하는 항비만용 식품 조성물 및 이의 제조방법

Also Published As

Publication number Publication date
US11564955B2 (en) 2023-01-31
WO2018093238A3 (ko) 2018-08-09
JP2019535828A (ja) 2019-12-12
KR20180056972A (ko) 2018-05-30
US20210315946A1 (en) 2021-10-14
JP7012736B2 (ja) 2022-02-14
WO2018093238A2 (ko) 2018-05-24

Similar Documents

Publication Publication Date Title
KR101912774B1 (ko) 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
CN112672749B (zh) 具有肥胖预防或治疗效果的新的长双歧杆菌菌株或鼠李糖乳杆菌菌株及其用途
EP2546330B1 (en) Lactic acid bacterium-containing preparation
JP6684966B2 (ja) 新規なラクトバチルス・サケイ及びそれを含む組成物
TWI461154B (zh) Obesity prevention or ameliorating agent
EP2223697A1 (en) Lactic acid bacterium-containing preparation
KR102585342B1 (ko) 락토바실러스 플란타룸 hac03 균주 및 가르시니아 캄보지아 추출물을 포함하는 항비만용 조성물
CN113499401A (zh) 一种治疗阿尔茨海默病的药物组合物及其制备方法和应用
KR101545551B1 (ko) 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
JP6793380B2 (ja) スクロース摂取による血糖値上昇を抑制する物質の評価方法、スクリーニング方法及び製造方法
KR102802964B1 (ko) 리모실락토바실러스 퍼멘툼 mg4295 균주를 포함하는 혈당 저하용 조성물
KR101797926B1 (ko) 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물
KR101074914B1 (ko) 미네랄과 아미노산이 강화된 발효 여주 및 우엉을 포함하는 비만 또는 고지혈증의 치료 또는 예방용 약학 조성물 및 그 제조 방법
KR20160141027A (ko) 아위버섯 물 추출물을 유효성분으로 함유하는 대사성질환의 예방 및 치료용 약학적 조성물 또는 건강기능성식품
US20200069748A1 (en) Human-derived lactobacillus frementum mg4231 or lactobacillus frementum mg4244 strain having anti-obesity activity and composition comprising same
KR102639561B1 (ko) 락토바실러스 플란타룸 nchbl-004 균주 또는 이의 배양액을 이용한 비만, 당뇨 또는 지방간을 포함하는 대사성 질환 예방, 치료 또는 개선용 조성물
KR20200047939A (ko) 발효 고추 및 발효 고추박을 함유하는 항당뇨 발효 조성물
KR20140017933A (ko) 당뇨병 개선 효과능이 있는 탱자 발효 조성물
KR102819116B1 (ko) 아이스플랜트 발효물을 포함하는 대사성 질환 예방 또는 개선용 조성물
KR102796656B1 (ko) 근 감소증 개선용 혼합균주 및 이를 포함하는 조성물
KR101535077B1 (ko) 인슐린 저항성 개선 효능을 가지는 비피도박테리움 락티스 hy8101 및 이를 유효성분으로 함유하는 제품
EP4659756A1 (en) Monascus pilosus strain, composition for preventing or treating nonalcoholic fatty liver disease and use of said monascus pilosus
KR102154124B1 (ko) 프로피오니박테리움 프레우덴레키 mj2 균주를 유효성분으로 포함하는 대사성 질환 및 비만 관련 대사 이상의 예방, 치료, 또는 개선용 조성물
KR20230165104A (ko) 락토바실러스 쿤케이 nchbl-003 균주 또는 이의 배양액을 포함하는 대사성 질환 예방, 치료 또는 개선용 조성물
KR20250091544A (ko) 메밀 새싹 추출물 및 프로바이오틱스 유익균을 포함하는 신바이오틱스 식품 조성물

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20161121

PA0201 Request for examination
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180201

Patent event code: PE09021S01D

PG1501 Laying open of application
E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20181019

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20181023

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20181024

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210927

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220920

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20241002

Start annual number: 7

End annual number: 7